Nektar Therapeutics (NKTR) Discusses 52-Week Topline Results From REZOLVE-AA Phase 2b Extension in Severe Alopecia Areata - Slideshow (NASDAQ:NKTR) 2026-04-20
Summary
2026-04-20. The following slide deck was published by Nektar Therapeutics in conjunction with this event.
Description
2026-04-20. The following slide deck was published by Nektar Therapeutics in conjunction with this event.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source